CNCE

Concert Pharmaceuticals, Inc.
CNCE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCE was delisted on the 3rd of March, 2023.

Back to rankings

48 hedge funds and large institutions have $78.7M invested in Concert Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.4M
2
+$9.24M
3
+$8.31M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$6.86M
5
WSA
Wall Street Associates
California
+$4.32M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$15.4M
2
$9.24M
3
$8.31M
4
$6.86M
5
$4.32M
6
$3.94M
7
$3.13M
8
$3.06M
9
$2.69M
10
$2.46M
11
$2.19M
12
$1.62M
13
$1.46M
14
$1.11M
15
$1.02M
16
$987K
17
$903K
18
$861K
19
$807K
20
$801K
21
$790K
22
$651K
23
$629K
24
$590K
25
$559K
1
2